Pharma firms upped lobbying 23% before TrumpRx launch
Drug companies involved in TrumpRx increased their lobbying efforts by 23% ahead of the program's launch, spending over $130 million in 2025.
Browsing Tag
Novo Nordisk
Novo, Lilly Drop as Trump Hypes ‘Reduced’ Ozempic Price
Novo Nordisk and Eli Lilly shares drop after Trump suggests the price of diabetes drug Ozempic could decrease to…
Drugmakers consent to second round of price talks
All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, have agreed to participate in the second…